{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:14:27Z","timestamp":1793985267740,"version":"4.8.0"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016321","name":"Lanzhou University First Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pharmthera.2026.109051","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:55:43Z","timestamp":1780530943000},"page":"109051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Disarming the \u201cNeural Hijack\u201d: Repurposing neuroactive drugs for cancer therapy"],"prefix":"10.1016","volume":"285","author":[{"given":"Ming-Zhu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ran","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/0008-5472.CAN-07-1183","article-title":"Nerve growth factor is a potential therapeutic target in breast cancer","volume":"68","author":"Adriaenssens","year":"2008","journal-title":"Cancer Research"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109051_bb0010","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.2174\/0929867328666210113165805","article-title":"Neurokinin-1 receptor (NK-1R) antagonists: Potential targets in the treatment of glioblastoma multiforme","volume":"28","author":"Afshari","year":"2021","journal-title":"Current Medicinal Chemistry"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109051_bb0015","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1002\/cncr.26117","article-title":"Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes","volume":"117","author":"Albo","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrc.2016.38","article-title":"Mechanisms of cancer dissemination along nerves","volume":"16","author":"Amit","year":"2016","journal-title":"Nature Reviews. Cancer"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109051_bb0025","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.1021\/acs.jmedchem.5c01459","article-title":"Repurposing drug metabolites into dual beta-adrenergic receptor-carbonic anhydrase modulators as potential tools for ocular disorders","volume":"68","author":"Ammara","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0030","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ncomms2413","article-title":"Src activation by beta-adrenoreceptors is a key switch for tumour metastasis","volume":"4","author":"Armaiz-Pena","year":"2013","journal-title":"Nature Communications"},{"issue":"45","key":"10.1016\/j.pharmthera.2026.109051_bb0035","doi-asserted-by":"crossref","first-page":"79298","DOI":"10.18632\/oncotarget.17837","article-title":"A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma","volume":"8","author":"Arrillaga-Romany","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnins.2014.00023","article-title":"Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis","volume":"8","author":"Assas","year":"2014","journal-title":"Frontiers in Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb0045","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1158\/0008-5472.CAN-05-1847","article-title":"Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma","volume":"66","author":"Ayala","year":"2006","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166746","article-title":"Targeting the tumor microenvironment: Potential strategy for cancer therapeutics","volume":"1869","author":"Babar","year":"2023","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0055","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: A comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"Journal of Thoracic Oncology"},{"issue":"7935","key":"10.1016\/j.pharmthera.2026.109051_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cell.2020.10.016","article-title":"Neurons release serine to support mRNA translation in pancreatic cancer","volume":"183","author":"Banh","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc3131","article-title":"Perineural invasion and associated pain in pancreatic cancer","volume":"11","author":"Bapat","year":"2011","journal-title":"Nature Reviews. Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm.4501","article-title":"Nociceptor sensory neurons suppress neutrophil and gammadelta T cell responses in bacterial lung infections and lethal pneumonia","volume":"24","author":"Baral","year":"2018","journal-title":"Nature Medicine"},{"issue":"8056","key":"10.1016\/j.pharmthera.2026.109051_bb0080","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","volume":"639","author":"Barron","year":"2025","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109051_bb0085","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: a population- based study","volume":"29","author":"Barron","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109051_bb0090","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: A population- based study","volume":"29","author":"Barron","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","article-title":"Dopamine, a neurotransmitter, influences the immune system","volume":"102","author":"Basu","year":"2000","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","article-title":"Dopamine, a neurotransmitter, influences the immune system","volume":"102","author":"Basu","year":"2000","journal-title":"Journal of Neuroimmunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59614-4","article-title":"Gabapentinoids confer survival benefit in human glioblastoma","volume":"16","author":"Bernstock","year":"2025","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10555-025-10249-3","article-title":"Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer","volume":"44","author":"Bloomer","year":"2025","journal-title":"Cancer Metastasis Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nature Medicine"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109051_bb0120","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","article-title":"beta-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy","volume":"77","author":"Bucsek","year":"2017","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0125","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00262-016-1929-z","article-title":"Schwann cells: a new player in the tumor microenvironment","volume":"66","author":"Bunimovich","year":"2017","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109051_bb0135","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/0008-5472.CAN-12-0764","article-title":"Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor","volume":"72","author":"Cavel","year":"2012","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.gastro.2008.09.029","article-title":"Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases","volume":"136","author":"Ceyhan","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb0145","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/ajg.2009.380","article-title":"Pancreatic neuropathy results in \"neural remodeling\" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer","volume":"104","author":"Ceyhan","year":"2009","journal-title":"The American Journal of Gastroenterology"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109051_bb0150","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/1078-0432.CCR-04-0059","article-title":"Depleted dopamine in gastric cancer tissues: Dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis","volume":"10","author":"Chakroborty","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0b013e31824104c5","article-title":"Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Chatterjee","year":"2012","journal-title":"The American Journal of Surgical Pathology"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109051_bb0160","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/0008-5472.CAN-24-1779","article-title":"Neural circuitries between the brain and peripheral solid tumors","volume":"84","author":"Chen","year":"2024","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0165","doi-asserted-by":"crossref","first-page":"G591","DOI":"10.1152\/ajpgi.00055.2008","article-title":"Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation","volume":"295","author":"Cheng","year":"2008","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109051_bb0170","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41388-024-02994-6","article-title":"Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR-211-5p\/GDNF","volume":"43","author":"Cheng","year":"2024","journal-title":"Oncogene"},{"issue":"7465","key":"10.1016\/j.pharmthera.2026.109051_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12479","article-title":"Bacteria activate sensory neurons that modulate pain and inflammation","volume":"501","author":"Chiu","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuron.2017.09.008","article-title":"The wound microenvironment reprograms schwann cells to invasive mesenchymal-like cells to drive peripheral nerve regeneration","volume":"96","author":"Clements","year":"2017","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0185","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nature Reviews. Cancer"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0195","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.14791\/btrt.2025.0024","article-title":"Neural vulnerabilities in glioblastoma: Rethinking therapy through neuroactive drug repurposing","volume":"13","author":"Colobon","year":"2025","journal-title":"Brain Tumor Research and Treatment"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nature Medicine"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109051_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115936","article-title":"The repurposing of non-peptide neurokinin-1 receptor antagonists as antitumor drugs: An urgent challenge for aprepitant","volume":"24","author":"Covenas","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109051_bb0215","doi-asserted-by":"crossref","first-page":"15936","DOI":"10.3390\/ijms242115936","article-title":"The repurposing of non-peptide neurokinin-1 receptor antagonists as antitumor drugs: An urgent challenge for aprepitant","volume":"24","author":"Cove\u00f1as","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.659055","article-title":"The role of neurodevelopmental pathways in brain tumors","volume":"9","author":"Curry","year":"2021","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.medj.2024.02.002","article-title":"Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs","volume":"5","author":"Darragh","year":"2024","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for off-label treatment of patients with Melanoma: Results from a cohort study","volume":"4","author":"De Giorgi","year":"2018","journal-title":"JAMA Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for off-label treatment of patients with melanoma","volume":"4","author":"De Giorgi","year":"2018","journal-title":"JAMA Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0240","article-title":"The Role of Schwann Cells in Cancer","volume":"6","author":"Deborde","year":"2022","journal-title":"Adv Biol (Weinh)"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0245","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI82658","article-title":"Schwann cells induce cancer cell dispersion and invasion","volume":"126","author":"Deborde","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0250","article-title":"An in vivo murine sciatic nerve model of perineural invasion","volume":"134","author":"Deborde","year":"2018","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphys.2012.00097","article-title":"Nerve-cancer interactions in the stromal biology of pancreatic cancer","volume":"3","author":"Demir","year":"2012","journal-title":"Frontiers in Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0260","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cancers2031513","article-title":"Neural invasion in pancreatic cancer: the past, present and future","volume":"2","author":"Demir","year":"2010","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nature Reviews. Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","article-title":"Impact of beta blockers on epithelial ovarian cancer survival","volume":"127","author":"Diaz","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"36","key":"10.1016\/j.pharmthera.2026.109051_bb0275","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/sj.onc.1206805","article-title":"Nerve growth factor overexpression and autocrine loop in breast cancer cells","volume":"22","author":"Dolle","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0280","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.apsb.2025.03.025","article-title":"The neuroscience of cancer: Focus on neuropeptidergic systems","volume":"15","author":"Dong","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108750","article-title":"Neurobiology of cancer: Adrenergic signaling and drug repurposing","volume":"264","author":"Dong","year":"2024","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0290","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41591-024-02969-w","article-title":"A prognostic neural epigenetic signature in high-grade glioma","volume":"30","author":"Drexler","year":"2024","journal-title":"Nature Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0300","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1038\/ncomms10517","article-title":"Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer","volume":"7","author":"Dubeykovskaya","year":"2016","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12032-025-02729-x","article-title":"Molecular mechanisms and clinical significance of perineural invasion in malignancies: the pivotal role of tumor-associated Schwann cells in cancer progression and metastasis","volume":"42","author":"Ebrahim","year":"2025","journal-title":"Medical Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0310","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1470-2045(04)01431-7","article-title":"Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters","volume":"5","author":"Entschladen","year":"2004","journal-title":"The Lancet Oncology"},{"issue":"7639","key":"10.1016\/j.pharmthera.2026.109051_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2023.02.011","article-title":"Propranolol reduces IFN-gamma driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer","volume":"110","author":"Falcinelli","year":"2023","journal-title":"Brain, Behavior, and Immunity"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb0325","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.4049\/jimmunol.1102147","article-title":"TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome","volume":"188","author":"Fernandes","year":"2012","journal-title":"Journal of Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0330","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","article-title":"Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment","volume":"41","author":"Fjaestad","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0335","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1038\/s41467-025-65048-9","article-title":"beta-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells","volume":"16","author":"Fjaestad","year":"2025","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0340","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-024-58440-w","article-title":"Vagus nerve signal has an inhibitory influence on the development of peritoneal metastasis in murine gastric cancer","volume":"14","author":"Futoh","year":"2024","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3892\/ijo.2015.3016","article-title":"Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells","volume":"47","author":"Garnier","year":"2015","journal-title":"International Journal of Oncology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109051_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070893","article-title":"Nerves and pancreatic cancer: New insights into a dangerous relationship","volume":"11","author":"Gasparini","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-016-0559-6","article-title":"Tryptophan hydroxylase 1 and 5-HT(7) receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling","volume":"15","author":"Gautam","year":"2016","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-016-0559-6","article-title":"Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling","volume":"15","author":"Gautam","year":"2016","journal-title":"Molecular Cancer"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0365","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrc.2017.106","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nature Reviews. Cancer"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109051_bb0370","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.cell.2025.06.012","article-title":"Targeting serotonin transporter boosts tumor-fighting T cells","volume":"188","author":"Gershon","year":"2025","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/djp456","article-title":"Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves","volume":"102","author":"Gil","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb0380","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/neuonc\/noy083","article-title":"An active role for neurons in glioma progression: making sense of Scherer's structures","volume":"20","author":"Gillespie","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0385","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240337","article-title":"Schwann cells in regeneration and cancer: An epithelial-mesenchymal transition perspective","volume":"15","author":"Gracia","year":"2025","journal-title":"Open Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0390","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pros.22564","article-title":"Use of \u03b2-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy","volume":"73","author":"Grytli","year":"2012","journal-title":"The Prostate"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0395","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pros.22564","article-title":"Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy","volume":"73","author":"Grytli","year":"2013","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0400","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","article-title":"Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling","volume":"31","author":"Hayakawa","year":"2017","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109051_bb0410","first-page":"E2008","article-title":"GFRalpha1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling","volume":"111","author":"He","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0415","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0420","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/glia.70032","article-title":"Interplay between schwann cells and peripheral cancers: Mechanisms and therapeutic targets in cancer progression","volume":"73","author":"He","year":"2025","journal-title":"Glia"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109051_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133220","article-title":"Blockage of cholinergic signaling via muscarinic acetylcholine receptor 3 inhibits tumor growth in human colorectal adenocarcinoma","volume":"13","author":"Hering","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0430","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12885-024-11846-1","article-title":"PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma","volume":"24","author":"Heuer","year":"2024","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0435","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative beta-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0440","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: A phase II randomized trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0445","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"The Lancet Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0450","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-021-06210-x","article-title":"Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer","volume":"188","author":"Hopson","year":"2021","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13402-025-01151-9","article-title":"Neural-tumor crosstalk and molecular targeting: mechanisms and therapeutic implications in cancer neuroscience","volume":"49","author":"Hou","year":"2026","journal-title":"Cellular Oncology (Dordrecht)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0460","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s42003-025-09006-7","article-title":"Small cell lung cancer induces synaptic scaling to alter neuronal excitability","volume":"8","author":"Houcek","year":"2025","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0465","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-024-02219-0","article-title":"Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment","volume":"24","author":"Huang","year":"2025","journal-title":"Molecular Cancer"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0470","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543776.2010.495121","article-title":"Neurokinin-1 receptor antagonists: a comprehensive patent survey","volume":"20","author":"Huang","year":"2010","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0475","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00423-025-03735-3","article-title":"Pancreatic resection with perioperative drug repurposing of propranolol and etodolac - the phase II randomized controlled PROSPER trial","volume":"410","author":"Huttner","year":"2025","journal-title":"Langenbeck's Archives of Surgery"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0480","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0485","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of Ca2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0490","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","article-title":"Machine and deep learning approaches for cancer drug repurposing","volume":"68","author":"Issa","year":"2021","journal-title":"Seminars in Cancer Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0495","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/cas.13975","article-title":"Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma","volume":"110","author":"Iwasaki","year":"2019","journal-title":"Cancer Science"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109051_bb0500","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1113\/JP270874","article-title":"The repair Schwann cell and its function in regenerating nerves","volume":"594","author":"Jessen","year":"2016","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0505","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cytogfr.2026.01.010","article-title":"The role of neurotransmitter signaling in colorectal cancer progression: Opportunities for drug repurposing","volume":"88","author":"Jiang","year":"2026","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0510","doi-asserted-by":"crossref","first-page":"1148706","DOI":"10.3389\/fphar.2023.1148706","article-title":"Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche","volume":"14","author":"Jin","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0515","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0520","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","article-title":"Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression","volume":"75","author":"Jobling","year":"2015","journal-title":"Cancer Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109051_bb0525","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.neuron.2025.08.015","article-title":"Novel approaches to clinical trial design in cancer neuroscience","volume":"113","author":"Jones","year":"2025","journal-title":"Neuron"},{"issue":"7873","key":"10.1016\/j.pharmthera.2026.109051_bb0530","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.pharmthera.2026.109051_bb0535","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1523\/JNEUROSCI.3532-16.2017","article-title":"Tweety-homolog 1 drives brain colonization of gliomas","volume":"37","author":"Jung","year":"2017","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0540","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41593-019-0430-3","article-title":"Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression","volume":"22","author":"Kamiya","year":"2019","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0545","doi-asserted-by":"crossref","first-page":"zcaf029","DOI":"10.1093\/narcan\/zcaf029","article-title":"Neural interaction explainable AI predicts drug response across cancers","volume":"7","author":"Keyl","year":"2025","journal-title":"NAR Cancer"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0550","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101126","article-title":"Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdifferentiation","volume":"60","author":"Krauss","year":"2025","journal-title":"Neoplasia"},{"issue":"7961","key":"10.1016\/j.pharmthera.2026.109051_bb0560","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0565","doi-asserted-by":"crossref","first-page":"2192098","DOI":"10.1080\/2162402X.2023.2192098","article-title":"Melanoma-associated repair-like Schwann cells suppress anti-tumor T-cells via 12\/15-LOX\/COX2-associated eicosanoid production","volume":"12","author":"Kruglov","year":"2023","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0570","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbi.2012.01.013","article-title":"Chronic stress enhances progression of acute lymphoblastic leukemia via beta-adrenergic signaling","volume":"26","author":"Lamkin","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0575","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cells10051226","article-title":"Glutamatergic mechanisms in glioblastoma and tumor-associated epilepsy","volume":"10","author":"Lange","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb0580","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41591-024-03224-y","article-title":"High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity","volume":"30","author":"Lee","year":"2024","journal-title":"Nature Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109051_bb0585","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.cell.2025.04.032","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0590","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cac2.12188","article-title":"Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0595","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cjp2.307","article-title":"Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours","volume":"9","author":"Li","year":"2023","journal-title":"The Journal of Pathology. Clinical Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188884","article-title":"Vagus innervation in the gastrointestinal tumor: Current understanding and challenges","volume":"1878","author":"Li","year":"2023","journal-title":"Biochimica Et Biophysica Acta. Reviews on Cancer"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109051_bb0605","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/cncr.24396","article-title":"Perineural invasion in cancer: a review of the literature","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0610","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175718","article-title":"Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer","volume":"949","author":"Lin","year":"2023","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40779-025-00661-9","article-title":"Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies","volume":"12","author":"Liu","year":"2025","journal-title":"Military Medical Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0625","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41568-023-00556-8","article-title":"The neural addiction of cancer","volume":"23","author":"Magnon","year":"2023","journal-title":"Nature Reviews Cancer"},{"issue":"6142","key":"10.1016\/j.pharmthera.2026.109051_bb0630","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109051_bb0635","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109051_bb0640","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1158\/0008-5472.CAN-08-1810","article-title":"The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma","volume":"68","author":"Marchesi","year":"2008","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0645","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12885-023-11797-z","article-title":"A phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol","volume":"24","author":"Mastall","year":"2024","journal-title":"BMC Cancer"},{"issue":"29","key":"10.1016\/j.pharmthera.2026.109051_bb0650","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/1759-7714.15075","article-title":"AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines","volume":"14","author":"Masumoto","year":"2023","journal-title":"Thoracic Cancer"},{"issue":"29","key":"10.1016\/j.pharmthera.2026.109051_bb0655","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/1759-7714.15075","article-title":"<scp>AMPAR<\/scp> receptor inhibitors suppress proliferation of human small cell lung cancer cell lines","volume":"14","author":"Masumoto","year":"2023","journal-title":"Thoracic Cancer"},{"issue":"7758","key":"10.1016\/j.pharmthera.2026.109051_bb0660","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","article-title":"Progenitors from the central nervous system drive neurogenesis in cancer","volume":"569","author":"Mauffrey","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2025.106205","article-title":"Candesartan, an angiotensin receptor blocker, prevents cognitive impairment in female mice with mammary cancer","volume":"132","author":"McCaffrey","year":"2026","journal-title":"Brain, Behavior, and Immunity"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109051_bb0670","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","article-title":"Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer","volume":"29","author":"Melhem-Bertrandt","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109051_bb0675","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","article-title":"Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer","volume":"29","author":"Melhem-Bertrandt","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0680","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6","article-title":"Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior","volume":"81","author":"Miknyoczki","year":"1999","journal-title":"International Journal of Cancer"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0685","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1172\/JCI129502","article-title":"beta2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells","volume":"129","author":"Mohammadpour","year":"2019","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0690","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","article-title":"Roadmap for the emerging field of cancer neuroscience","volume":"181","author":"Monje","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0695","doi-asserted-by":"crossref","first-page":"17553","DOI":"10.1038\/s41598-022-22377-9","article-title":"BDNF\/TRKB axis provokes EMT progression to induce cell aggressiveness via crosstalk with cancer-associated fibroblasts in human parotid gland cancer","volume":"12","author":"Moriwaki","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.07.024","article-title":"Involvement of substance P and the NK-1 receptor in cancer progression","volume":"48","author":"Munoz","year":"2013","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109051_bb0705","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Munoz","year":"2014","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061659","article-title":"The neurokinin-1 receptor antagonist aprepitant, a new drug for the treatment of hematological malignancies: Focus on acute myeloid leukemia","volume":"9","author":"Munoz","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0715","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/jcm9061659","article-title":"The neurokinin-1 receptor antagonist aprepitant, a new drug for the treatment of hematological malignancies: Focus on acute myeloid leukemia","volume":"9","author":"Mu\u00f1oz","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092682","article-title":"The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?","volume":"12","author":"Munoz","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb0725","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/cancers12092682","article-title":"The neurokinin-1 receptor antagonist aprepitant: An intelligent bullet against cancer?","volume":"12","author":"Mu\u00f1oz","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030520","article-title":"Radiotherapy plus the neurokinin-1 receptor antagonist aprepitant: A potent therapeutic strategy for the treatment of diffuse intrinsic pontine glioma","volume":"17","author":"Munoz","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0735","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cancers17030520","article-title":"Radiotherapy plus the neurokinin-1 receptor antagonist aprepitant: A potent therapeutic strategy for the treatment of diffuse intrinsic pontine glioma","volume":"17","author":"Mu\u00f1oz","year":"2025","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0740","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/092986710790416308","article-title":"A new frontier in the treatment of cancer: NK-1 receptor antagonists","volume":"17","author":"Munoz","year":"2010","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0745","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2174\/138945011795528796","article-title":"The NK-1 receptor: A new target in cancer therapy","volume":"12","author":"Munoz","year":"2011","journal-title":"Current Drug Targets"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109051_bb0750","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/onc.2015.302","article-title":"Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis","volume":"35","author":"Nagaraja","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0755","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2018-316451","article-title":"Stromal biology and therapy in pancreatic cancer: ready for clinical translation?","volume":"68","author":"Neesse","year":"2019","journal-title":"Gut"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109051_bb0760","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160152","article-title":"Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse","volume":"132","author":"Nie","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0765","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/2326-6066.CIR-17-0401","article-title":"beta-adrenergic signaling impairs antitumor CD8(+) T-cell responses to B-cell lymphoma immunotherapy","volume":"6","author":"Nissen","year":"2018","journal-title":"Cancer Immunology Research"},{"issue":"7607","key":"10.1016\/j.pharmthera.2026.109051_bb0770","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0775","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0780","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.2012.499","article-title":"Brain-derived neurotrophic factor\/tropomyosin-related kinase B pathway in gastric cancer","volume":"108","author":"Okugawa","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109051_bb0785","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00432-025-06262-2","article-title":"Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers","volume":"151","author":"O'Logbon","year":"2025","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"7580","key":"10.1016\/j.pharmthera.2026.109051_bb0790","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature16071","article-title":"Brain tumour cells interconnect to a functional and resistant network","volume":"528","author":"Osswald","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0795","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.21873\/anticanres.15205","article-title":"TrkB\/BDNF signaling could be a new therapeutic target for pancreatic cancer","volume":"41","author":"Oyama","year":"2021","journal-title":"Anticancer Research"},{"issue":"8028","key":"10.1016\/j.pharmthera.2026.109051_bb0800","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","article-title":"Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis","volume":"633","author":"Padmanaban","year":"2024","journal-title":"Nature"},{"issue":"7862","key":"10.1016\/j.pharmthera.2026.109051_bb0805","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","article-title":"NF1 mutation drives neuronal activity-dependent initiation of optic glioma","volume":"594","author":"Pan","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0810","doi-asserted-by":"crossref","DOI":"10.1136\/bmjonc-2025-000842","article-title":"Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers","volume":"4","author":"Parathan","year":"2025","journal-title":"bmj Oncology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109051_bb0815","doi-asserted-by":"crossref","first-page":"22501","DOI":"10.18632\/oncotarget.15019","article-title":"Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFalpha in a murine pancreatic cancer model","volume":"8","author":"Partecke","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0820","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex--linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nature Reviews. Endocrinology"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109051_bb0825","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/0008-5472.CAN-03-4046","article-title":"Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models","volume":"64","author":"Peer","year":"2004","journal-title":"Cancer Research"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109051_bb0830","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/0008-5472.CAN-03-4046","article-title":"Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models","volume":"64","author":"Peer","year":"2004","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0835","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2018.04.006","article-title":"Blocking neuronal signaling to immune cells treats streptococcal invasive infection","volume":"173","author":"Pinho-Ribeiro","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0840","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jtho.2020.01.016","article-title":"New approaches to SCLC Therapy: From the laboratory to the clinic","volume":"15","author":"Poirier","year":"2020","journal-title":"Journal of Thoracic Oncology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109051_bb0845","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0850","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: Anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0855","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0860","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.ajpath.2014.08.009","article-title":"ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer","volume":"184","author":"Pundavela","year":"2014","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0865","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2018","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0870","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0875","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0880","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2018.00164","article-title":"Adrenergic signaling: A targetable checkpoint limiting development of the antitumor immune response","volume":"9","author":"Qiao","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0885","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","article-title":"beta-Adrenergic signaling blocks murine CD8(+) T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress","volume":"68","author":"Qiao","year":"2019","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.109051_bb0890","article-title":"Single-cell sequencing uncovers sensory neuron-mediated CGRP signaling as a driver of sarcoma progression","volume":"122","author":"Ramesh","year":"2025","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0895","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2018.07.006","article-title":"Therapeutic potential of the vagus nerve in cancer","volume":"202","author":"Reijmen","year":"2018","journal-title":"Immunology Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb0900","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ccell.2018.10.010","article-title":"beta2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer","volume":"34","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb0905","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","article-title":"Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness","volume":"8","author":"Renz","year":"2018","journal-title":"Cancer Discovery"},{"issue":"289","key":"10.1016\/j.pharmthera.2026.109051_bb0910","doi-asserted-by":"crossref","first-page":"289ra86","DOI":"10.1126\/scitranslmed.aaa8103","article-title":"SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma","volume":"7","author":"Robert","year":"2015","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109051_bb0915","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41419-019-2116-x","article-title":"Schwann cells support oncogenic potential of pancreatic cancer cells through TGFbeta signaling","volume":"10","author":"Roger","year":"2019","journal-title":"Cell Death & Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0920","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0006-2952(02)01218-2","article-title":"Glutamate antagonists limit tumor growth","volume":"64","author":"Rzeski","year":"2002","journal-title":"Biochemical Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0925","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0006-2952(02)01218-2","article-title":"Glutamate antagonists limit tumor growth","volume":"64","author":"Rzeski","year":"2002","journal-title":"Biochemical Pharmacology"},{"issue":"8087","key":"10.1016\/j.pharmthera.2026.109051_bb0930","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41586-025-09434-9","article-title":"Functional synapses between neurons and small cell lung cancer","volume":"646","author":"Sakthivelu","year":"2025","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb0935","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0940","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061694","article-title":"Peptidergic systems and cancer: Focus on tachykinin and calcitonin\/calcitonin gene-related peptide families","volume":"15","author":"Sanchez","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb0945","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/cancers15061694","article-title":"Peptidergic systems and cancer: focus on tachykinin and calcitonin\/calcitonin gene-related peptide families","volume":"15","author":"S\u00e1nchez","year":"2023","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109051_bb0950","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0955","doi-asserted-by":"crossref","first-page":"H1554","DOI":"10.1152\/ajpheart.00272.2004","article-title":"Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells","volume":"287","author":"Sarkar","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb0960","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","article-title":"The immunoregulatory role of dopamine: An update","volume":"24","author":"Sarkar","year":"2010","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109051_bb0965","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2018.06.016","article-title":"Serotonin and human cancer: A critical view","volume":"161","author":"Sarrouilhe","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0970","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1566524015666150114113411","article-title":"Serotonin and cancer: what is the link?","volume":"15","author":"Sarrouilhe","year":"2015","journal-title":"Current Molecular Medicine"},{"issue":"8087","key":"10.1016\/j.pharmthera.2026.109051_bb0975","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41586-025-09492-z","article-title":"Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis","volume":"646","author":"Savchuk","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb0980","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.suronc.2017.01.007","article-title":"The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis","volume":"26","author":"Schorn","year":"2017","journal-title":"Surgical Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb0985","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrc2590","article-title":"Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?","volume":"9","author":"Schuller","year":"2009","journal-title":"Nature Reviews. Cancer"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081357","article-title":"The impact of beta blockers on survival in cancer patients: A systematic review and meta-analysis","volume":"17","author":"Sharma","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb0995","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S1470-2045(21)00596-9","article-title":"Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities","volume":"23","author":"Shi","year":"2022","journal-title":"The Lancet Oncology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109051_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223541","article-title":"Tumor-induced T cell polarization by schwann cells","volume":"11","author":"Shurin","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1005","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/0008-5472.CAN-16-0899","article-title":"PanIN neuroendocrine cells promote tumorigenesis via neuronal cross-talk","volume":"77","author":"Sinha","year":"2017","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109051_bb1010","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb1015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/hep.23441","article-title":"Serotonin promotes tumor growth in human hepatocellular cancer","volume":"51","author":"Soll","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1020","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/0008-5472.CAN-06-2484","article-title":"M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion","volume":"67","author":"Song","year":"2007","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb1025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2008.05301.x","article-title":"A role for glutamate in growth and invasion of primary brain tumors","volume":"105","author":"Sontheimer","year":"2008","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb1030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2008.05301.x","article-title":"A role for glutamate in growth and invasion of primary brain tumors","volume":"105","author":"Sontheimer","year":"2008","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb1035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","article-title":"Multimodal data fusion for cancer biomarker discovery with deep learning","volume":"5","author":"Steyaert","year":"2023","journal-title":"Nature Machine Intelligence"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb1040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cell.2020.04.001","article-title":"A deep learning approach to antibiotic discovery","volume":"181","author":"Stokes","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb1045","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","article-title":"Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma","volume":"74","author":"Stopczynski","year":"2014","journal-title":"Cancer Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb1050","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.7150\/thno.42440","article-title":"Tumor-neuroglia interaction promotes pancreatic cancer metastasis","volume":"10","author":"Su","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1055","doi-asserted-by":"crossref","first-page":"1058667","DOI":"10.1155\/2022\/1058667","article-title":"Schwann cells in the tumor microenvironment: Need more attention","volume":"2022","author":"Sun","year":"2022","journal-title":"Journal of Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb1060","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb1065","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nature Medicine"},{"issue":"7986","key":"10.1016\/j.pharmthera.2026.109051_bb1070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nature Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1080","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00262-023-03445-z","article-title":"Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases","volume":"72","author":"Thapa","year":"2023","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109051_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101203","article-title":"Acetylcholine receptor activation as a modulator of glioblastoma invasion","volume":"8","author":"Thompson","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1090","article-title":"KRAS\/ACTN4\/p65-NR2A axis mediates glutamine-glutamate metabolic coupling between schwann cells and pancreatic cancer promoting perineural invasion","author":"Tian","year":"2025","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1095","series-title":"Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma","author":"Tobochnik","year":"2024"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1100","series-title":"Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma","author":"Tobochnik","year":"2024"},{"issue":"36","key":"10.1016\/j.pharmthera.2026.109051_bb1105","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0800767105","article-title":"Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide","volume":"105","author":"Toda","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb1110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11523-025-01184-y","article-title":"The efficacy and safety of beta-blockers and immune checkpoint inhibitors in patients with cancer: A systematic review and meta-analysis","volume":"20","author":"Tokunaga","year":"2025","journal-title":"Targeted Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nature Medicine"},{"issue":"6917","key":"10.1016\/j.pharmthera.2026.109051_bb1120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109051_bb1125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"7775","key":"10.1016\/j.pharmthera.2026.109051_bb1130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109051_bb1135","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","article-title":"Glioblastoma hijacks neuronal mechanisms for brain invasion","volume":"185","author":"Venkataramani","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb1140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trecan.2016.12.008","article-title":"Neuronal activity in ontogeny and oncology","volume":"3","author":"Venkatesh","year":"2017","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb1145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"issue":"7673","key":"10.1016\/j.pharmthera.2026.109051_bb1150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"issue":"7775","key":"10.1016\/j.pharmthera.2026.109051_bb1155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb1160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109051_bb1165","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Annals of Oncology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109051_bb1170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184594","article-title":"Perineural invasion and associated pain transmission in pancreatic cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-025-02396-6","article-title":"Hijacking homeostasis: the brain-body neural circuitry in tumor pathogenesis and emerging therapeutic frontiers","volume":"24","author":"Wang","year":"2025","journal-title":"Molecular Cancer"},{"issue":"8103","key":"10.1016\/j.pharmthera.2026.109051_bb1180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41586-025-10028-8","article-title":"Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis","volume":"650","author":"Wei","year":"2026","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1185","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: State of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1190","doi-asserted-by":"crossref","first-page":"1650117","DOI":"10.3389\/fimmu.2025.1650117","article-title":"Perineural invasion and the \"cold\" tumor microenvironment in pancreatic cancer: mechanisms of crosstalk and therapeutic opportunities","volume":"16","author":"Xu","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109051_bb1195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.trecan.2025.07.004","article-title":"CGRP-mediated neural addiction in tumor dynamic remodeling","volume":"11","author":"Xu","year":"2025","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13046-026-03648-z","article-title":"Paroxetine repurposing enhances antitumor immunity via SPOP-mediated PD-L1 ubiquitination and proteasomal degradation","volume":"45","author":"Xu","year":"2026","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1205","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nature Communications"},{"issue":"8060","key":"10.1016\/j.pharmthera.2026.109051_bb1210","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA(2) suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109051_bb1215","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1097\/JS9.0000000000003721","article-title":"Schwann cells drive tumor progression through neuro-tumor crosstalk","volume":"112","author":"Yang","year":"2025","journal-title":"International Journal of Surgery"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109051_bb1220","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.ccell.2025.07.024","article-title":"Long-range cholinergic input promotes glioblastoma progression","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb1225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","article-title":"Nerves in cancer","volume":"20","author":"Zahalka","year":"2020","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-025-01748-5","article-title":"The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities","volume":"18","author":"Zhang","year":"2025","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2026.109051_bb1235","doi-asserted-by":"crossref","first-page":"1635331","DOI":"10.3389\/fimmu.2025.1635331","article-title":"Impact of beta blockers on cancer neuroimmunology: a systematic review and meta-analysis of survival outcomes and immune modulation","volume":"16","author":"Zhang","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1240","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02364-y","article-title":"Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer","volume":"11","author":"Zhang","year":"2026","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109051_bb1245","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2026.01.001","article-title":"Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment","volume":"189","author":"Zhang","year":"2026","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13046-021-02198-w","article-title":"Autophagic Schwann cells promote perineural invasion mediated by the NGF\/ATG7 paracrine pathway in pancreatic cancer","volume":"41","author":"Zhang","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"250","key":"10.1016\/j.pharmthera.2026.109051_bb1255","doi-asserted-by":"crossref","first-page":"250ra115","DOI":"10.1126\/scitranslmed.3009569","article-title":"Denervation suppresses gastric tumorigenesis","volume":"6","author":"Zhao","year":"2014","journal-title":"Science Translational Medicine"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109051_bb1260","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/0008-5472.CAN-18-1702","article-title":"Schwann cells augment cell spreading and metastasis of lung cancer","volume":"78","author":"Zhou","year":"2018","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109051_bb1265","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2017.08.018","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109051_bb1270","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1200\/JCO.1999.17.8.2419","article-title":"Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer","volume":"17","author":"Zhu","year":"1999","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109051_bb1275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41419-025-07543-x","article-title":"Single-cell analysis reveals that GFAP(+) dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate\/HMGB1 axis","volume":"16","author":"Zu","year":"2025","journal-title":"Cell Death & Disease"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:22:17Z","timestamp":1783603337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":255,"alternative-id":["S0163725826000781"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109051","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disarming the \u201cNeural Hijack\u201d: Repurposing neuroactive drugs for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109051"}}